- Mike Richards, national clinical director for cancer and end of life care, Department of Health, London
- Mike.Richards{at}ncat.nhs.uk
Dear Susan
Your letter raises several important issues. These include the current state of the evidence relating to the benefits and harms of breast screening; how this information is communicated to women in order to promote informed choice; and the process by which decisions on screening are made in this country, including my own role. I welcome this opportunity to discuss all these issues.
When I became national cancer director 12 years ago the NHS breast screening programme was one of the few aspects of cancer service delivery that was generally judged to be working well. Broad decisions on screening programmes were, and still are, taken by the independent UK National Screening Committee, which advises ministers in all four UK countries. …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking